Dr. Hana Hybasek Dzurikova, MRCVS, PGCert MEd
3. October 2024

STEMI Mimics: Spot Subtle Impostors of Myocardial Infarction

STEMI-mimics-cover

The diagnosis of ST-Elevation Myocardial Infarction (STEMI) is a time-sensitive clinical challenge with critical implications for morbidity and mortality1. However, identifying a true STEMI based solely on ECG changes is not always straightforward, as a number of other conditions, collectively termed STEMI mimics, can produce ST-segment elevations without underlying myocardial infarction2. Misinterpreting these mimics as true STEMI can lead to unnecessary cath lab activations, resulting in invasive procedures that carry inherent risks3.

While the ECG is a crucial rule-in test for STEMI diagnosis, it is not a reliable rule-out test. This means that while significant ST-elevation on an ECG strongly suggests myocardial infarction and warrants urgent action, the absence of these findings does not necessarily exclude acute coronary syndromes (ACS)4. It is critical to correlate ECG findings with the patient’s clinical presentation, symptoms, and additional diagnostic markers, such as troponin levels, to ensure an accurate diagnosis5.

In this article, we explore the most common STEMI mimics, their clinical and ECG characteristics, and the role of advanced diagnostic tools, including AI-driven solutions, in aiding accurate and timely diagnosis.

What Are STEMI Mimics?

STEMI mimics are conditions that cause ST-segment elevation on an ECG but are not due to acute coronary occlusion. These may be cardiac or non-cardiac in origin, and each presents a unique challenge to the clinician2

Unnecessary cath lab activations due to STEMI mimics are relatively common, with studies estimating that approximately 10-36% of patients presenting with ST-segment elevation on ECGs do not have an acute coronary occlusion upon angiography6,7. Misdiagnosing these conditions as STEMI can lead to inappropriate interventions, exposing the patient to potential complications of invasive procedures, such as contrast-induced nephropathy, radiation exposure, bleeding, and others6,7.

The ability to distinguish these mimics is essential for patient safety and resource optimization in busy emergency settings7.

Common STEMI Mimics and Their Diagnostic Pitfalls

Some of the most notable conditions mimicking STEMI include subarachnoid hemorrhage, Left Bundle Branch Block (LBBB), pericarditis, spontaneous coronary artery dissection (SCAD), hyperkalemia, ventricular paced rhythm, Brugada syndrome, hypothermia, Prinzmetal’s/Variant angina, pulmonary embolism, Takotsubo cardiomyopathy, ventricular aneurysm, left ventricular hypertrophy, early repolarization, and thoracic aortic dissection. Each of these conditions can present with ECG changes that resemble STEMI, yet they require different treatment approaches, underscoring the importance of careful clinical evaluation8.

Below, we examine several STEMI mimics, focusing on their ECG characteristics, the mechanisms behind their resemblance to STEMI, and some of the key clinical clues that help differentiate them.

Pericarditis

Pericarditis is an inflammatory condition affecting the pericardium, which can be of infectious (often viral) or non-infectious origin, including autoimmune diseases, cancer, post-cardiac injury syndromes, post-myocardial infarction syndromes, Dressler’s syndrome and others9,11.

ECG Features of Pericarditis

  • Diffuse ST-segment elevation across multiple leads, typically concave (upward-sloping).
  • PR-segment depression in leads with ST-elevation, particularly in the inferior leads.
  • Absence of reciprocal changes typically seen in STEMI10.
STEMI Mimics ECG Features of Pericarditis
Figure: There is significant ST elevation in multiple leads (V4-6, I, II, III, aVF) with reciprocal ST depression in aVR and V1. Some leads show large T waves, suggestive of hyperacute T waves, while others, such as aVF, display ST elevation without prominent T waves. In distinguishing between conditions like OMI and pericarditis, it’s important to note that OMI typically shows both large T waves and significant ST elevation, whereas pericarditis often presents with relatively smaller T waves in comparison to the degree of ST elevation. In this case, the patient was ultimately diagnosed with traumatic uncomplicated pericarditis. (Steven Smith Blog, digitized by PMcardio Digitize).

Clinical Clues

  • Sharp, pleuritic chest pain that worsens with inspiration or lying down and improves when sitting upright.
  • Pericardial friction rub on auscultation.
  • Absence of elevated troponin levels, or mild elevation if myocarditis is also present10.

Why It Mimics STEMI

Pericarditis can lead to localized ST elevation, but unlike STEMI, it typically lacks reciprocal ST depression, except in leads aVR and V1. Both conditions can produce concave ST elevation, but only STEMI typically results in convex or horizontal ST elevation. Additionally, if the ST elevation is greater in lead III than in lead II, this is a strong indicator of STEMI. PR-segment depression is mostly associated with viral pericarditis and tends to be a transient, early feature, lasting only a few hours12.

Left Ventricular Hypertrophy (LVH)

LVH results from chronic pressure overload, often due to long-standing hypertension or aortic stenosis. The hypertrophied myocardium alters the electrical conduction patterns, leading to ST-segment abnormalities on the ECG13.

ECG Features of Left Ventricular Hypertrophy:

  • High-voltage QRS complexes, especially in the precordial leads (V1-V6).
  • ST-segment elevation in the anterior leads (V1-V3), often with T-wave inversions.

Strain pattern with ST-depression and T-wave inversions in the lateral leads14.

Stemi Mimics ECG Left Ventricular Hypertrophy
Figure: There is deep ST depression and T-wave inversions that are discordant with the large voltage R-waves, which are reflective of profound left ventricular hypertrophy (LVH) as confirmed by the echo. These ST-T changes do not represent ischemia but are secondary to the significant depolarization abnormalities caused by the increased LV mass. However, these changes could potentially mask underlying ischemia. (Steven Smith Blog, digitized by PMcardio Digitize).

Clinical Clues:

  • History of hypertension or aortic valve disease.
  • Echocardiographic evidence of hypertrophy.

Why It Mimics STEMI

The elevated voltage in the anterior leads and associated strain pattern can mimic an anteroseptal infarction. LVH-induced repolarization abnormalities can lead to confusion, especially in the absence of a clear clinical picture of acute coronary syndrome15.

Early Repolarization

Early repolarization is a benign ECG variant most commonly seen in young, healthy individuals, particularly athletes. It represents a variation in the electrical activity of the heart’s repolarization phase16.

ECG Features of Early Repolarization:

  • ST-segment elevation, typically concave, in the precordial and inferior leads.
  • Notching or slurring of the J-point, especially in the lateral leads.
  • No reciprocal ST-segment depression or evolving ECG changes17.
STEMI Mimics Early Repolarization
Figure: New diffuse ST elevation with a QTc of 384 and a formula of 19.1. The ST axis is approximately 30 degrees, with ST elevation in leads I, aVL, II, and aVF but not III, and no reciprocal ST depression except in aVR. This pattern is characteristic of pericarditis or diffuse early repolarization. Given the high T-wave voltage and elevated T/ST ratio, early repolarization is more likely. Well-formed J-waves are also present, further supporting early repolarization. (Steven Smith Blog, digitized by PMcardio Digitize).

Clinical Clues:

  • Asymptomatic or discovered incidentally.
  • No associated chest pain or cardiac risk factors16,18.

Why It Mimics STEMI

Early repolarization can closely mimic the ST-elevations seen in anterior or inferior STEMI, especially when J-point notching or slurring is present. Differentiation relies on the absence of clinical symptoms, reciprocal changes, and the stability of the ECG over time16.

Previously Diagnosed Left Bundle Branch Block (LBBB)

LBBB is a conduction abnormality that affects the left ventricle, causing delayed depolarization and abnormal repolarization patterns. While an old, previously diagnosed LBBB is generally not concerning and often reflects underlying structural heart disease or chronic conditions, a new or presumed new LBBB may raise suspicion for an acute myocardial infarction (OMI), especially in the context of other clinical signs of ischemia19,20.

This can be particularly challenging when interpreting the ECG, as LBBB alters the ST-segment, potentially masking or mimicking ischemic changes. In patients with suspected acute coronary syndrome, the presence of new or presumed new LBBB may raise concern for an underlying ischemic event20.

ECG Features of Previously Diagnosed LBBB ECG :

  • Wide QRS complexes (>120ms).
  • Discordant ST-segments (ST-segment elevation in leads with a predominantly negative QRS and depression in leads with positive QRS complexes).
  • Absence of normal septal Q-waves in leads I, aVL, V5, and V621.
STEMI Mimics ECG Features of Previously Diagnosed LBBB ECG
Figure: Sinus rhythm with LBBB and appropriate discordant ST changes: no concordant ST elevation, no concordant ST depression in V1-V3, and no evidence of excessive discordance.  (Steven Smith Blog, digitized by PMcardio Digitize).

Clinical Clues:

  • Often seen in patients with underlying cardiomyopathy or ischemic heart disease.
  • Symptomatology may range from asymptomatic to severe heart failure19.

Why It Mimics STEMI

LBBB creates significant abnormalities in both the depolarization and repolarization of the ventricles, making it difficult to interpret ST-segments. This necessitates the use of additional diagnostic tools, such as coronary angiography, or more sophisticated AI-powered ECG interpretation models, like PMcardio, which can accurately interpret complex conduction abnormalities in LBBB and paced rhythms22.

Brugada Syndrome

Brugada syndrome is a genetic condition affecting the sodium channels of the cardiomyocytes, specifically through mutations in the SCN5A gene, predisposing individuals to ventricular arrhythmias and sudden cardiac death23,24.

ECG Features of Brugada Syndrome

  • ST-segment elevation in the right precordial leads (V1-V3) with a coved or saddleback pattern25.
  • T-wave inversion in the right precordial leads.
  • Right bundle branch block (RBBB) pattern may also be present26.
STEMI Mimics Brugada Syndrome ECG Features
Figure: Sinus rhythm with a mostly normal QRS. Abnormal ST elevation in V1-V3 and possible ST depression in V5-6 could suggest anterior/septal/RV OMI, but V2 morphology may also indicate a Brugada pattern or phenocopy. Given this patient’s symptoms of weakness and fever, without chest pain or dyspnea, Brugada pattern is much more likely. (Steven Smith Blog, digitized by PMcardio Digitize)

Clinical Clues:

  • Typically presents in young men with a history of syncope, palpitations, or sudden cardiac arrest23.
  • Family history of sudden cardiac death or arrhythmias24.
  • Typically presents without chest pain and can be exacerbated by fever, which increases the risk of arrhythmias due to the temperature sensitivity of sodium channels27.

Why It Mimics STEMI

Brugada syndrome can present with ST-segment elevation in the anterior leads, mimicking a STEMI involving the LAD territory. The absence of reciprocal changes and the coved morphology of the ST-elevation are key distinguishing features25.

Hyperkalemia

Hyperkalemia alters cardiac depolarization and repolarization due to elevated extracellular potassium levels, affecting the resting membrane potential of cardiac myocytes28.

ECG Features of Hyperkalemia:

  • Peaked T-waves, particularly in the precordial leads.
  • Flattening or absence of P-waves.
  • Wide QRS complexes that can merge with ST-segments, creating a sine-wave appearance in severe cases29.
Stemi mimics ECG Features of Hyperkalemia
Figure: This ECG pattern is indicative of hyperkalemia. Hyperkalemia can mimic various pseudoSTEMI or pseudoOMI presentations, such as ST elevation, ST depression, and prominent T-waves. (Steven Smith Blog, digitized by PMcardio Digitize)

Clinical Clues:

  • History of renal failure, potassium-sparing diuretic use, or other causes of hyperkalemia.
  • Symptoms of muscle weakness, fatigue, or arrhythmias28,30.

Why It Mimics STEMI

Severe hyperkalemia can cause broad ST-elevation and wide QRS complexes that may resemble ischemic changes on the ECG. The absence of reciprocal changes, the clinical context, and rapid normalization of the ECG after correcting potassium levels are important clues31.

The Role of Advanced Diagnostics in Identifying STEMI Mimics

In the high-pressure environment of emergency care, where minutes matter, distinguishing between true STEMI and STEMI mimics can be a daunting task. While clinical context, patient history, and laboratory findings (such as troponin levels) are essential, the ECG remains the cornerstone of diagnosis. However, traditional ECG interpretation can be challenging in the presence of conduction abnormalities, hypertrophic changes, or benign variants.

This is where PMcardio offers a distinct advantage. By utilizing advanced deep learning algorithms trained on extensive datasets of ECGs, our AI is capable of distinguishing true myocardial infarction from common STEMI mimics with high precision22. The tool analyzes patterns that may be difficult to detect with the naked eye, reducing unnecessary cath lab activations and invasive procedures.

Conclusion

STEMI mimics pose a significant challenge to emergency care providers, with the potential for both over- and under-treatment of patients presenting with chest pain and ST-segment elevation. Careful ECG interpretation, clinical context, and advanced diagnostic tools are essential in differentiating these conditions from true STEMI. PMcardio, the AI-powered ECG platform offers clinicians an invaluable tool in making these critical decisions, ensuring that patients receive the right diagnosis and treatment32,33.

References

  1. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2018;39(2):119-177.
  2. O’Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction. Circulation. 2013;127(4).
  3. Naidu SS, Abbott JD, Bagai J, Blankenship J, Garcia S, Iqbal SN, et al. SCAI expert consensus update on best practices in the cardiac catheterization laboratory: endorsed by the American College of Cardiology, the American Heart Association, and the Heart Rhythm Society. Catheter Cardiovasc Interv. 2021;98(2):255-276. doi:10.1002/ccd.29744.
  4. Smith SW, Diercks DB, Lozano JV. Emergency cardiovascular care update: ST-elevation myocardial infarction and STEMI mimics. Emerg Med Clin North Am. 2018;36(3):491-508.
  5. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138(20).
  6. Larson DM, Menssen KM, Sharkey SW, et al. “False-positive” cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA. 2007;298(23):2754-2760. doi:10.1001/jama.298.23.2754.
  7. McCabe JM, Armstrong EJ, Kulkarni A, et al. Prevalence and factors associated with false-positive ST-segment elevation myocardial infarction diagnoses at primary percutaneous coronary intervention-capable centers: A report from the Activate-SF registry. Arch Intern Med. 2012;172(11):864-871. doi:10.1001/archinternmed.2012.157.
  8. Daley SM. STEMI mimics: A mnemonic. Available from: https://litfl.com/stemi-mimics-a-mnemonic [Accessed September 2024]
  9. Imazio M, Gaita F, LeWinter M. Evaluation and Treatment of Pericarditis: A Systematic Review. JAMA. 2015;314(14):1498-1506. doi:10.1001/jama.2015.12763.
  10. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2015;36(42):2921-2964. doi:10.1093/eurheartj/ehv318.
  11. Spodick DH. Acute Pericarditis: Current Concepts and Practice. JAMA. 2003;289(9):1150-1153. doi:10.1001/jama.289.9.1150.
  12. Pericarditis ECG Library. Life in the Fast Lane. Available from: https://litfl.com/pericarditis-ecg-library/. [Accessed 24 September 2024].
  13. Hancock EW, Deal BJ, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association. Circulation. 2009;119(10). doi:10.1161/CIRCULATIONAHA.108.191097.
  14. Goldberger AL. Clinical Electrocardiography: A Simplified Approach. 8th ed. Philadelphia: Elsevier; 2012.
  15. Okin PM, Devereux RB, Nieminen MS, et al. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the LIFE Study. Eur Heart J. 2009;30(6):714-721. doi:10.1093/eurheartj/ehp008.
  16. Macfarlane PW, Antzelevitch C, Haissaguerre M, Huikuri HV, Potse M, Rosso R, et al. The Early Repolarization Pattern: A Consensus Paper. J Am Coll Cardiol. 2015;66(4):470–7.
  17. Rezus C, Floria M, Moga VD, Sirbu O, Dima N, Ionescu SD, Ambarus V. Early repolarization syndrome: electrocardiographic signs and clinical implications. Ann Noninvasive Electrocardiol. 2014 Jan;19(1):15-22. doi: 10.1111/anec.12113. Epub 2013 Sep 30. PMID: 24118137; PMCID: PMC6932182.
  18. Klatsky AL, Oehm R, Cooper RA, Udaltsova N, Armstrong MA. The early repolarization normal variant electrocardiogram: correlates and consequences. Am J Med. 2003;115(3):171–7.
  19. Birnbaum Y, Wilson JM, Fiol M, de Luna AB, Eskola M, Nikus K. ECG diagnosis and classification of acute coronary syndromes. Ann Noninvasive Electrocardiol. 2014;19(1):4-14.
  20. Sgarbossa EB, Pinski SL, Barbagelata A, Underwood DA, Gates KB, Topol EJ, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. N Engl J Med. 1996;334(8):481-7.
  21. Surawicz B, Childers R, Deal BJ, Gettes LS, Bailey JJ, Gorgels A, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Circulation. 2009;119(10)
  22. Herman R, Meyers HP, Smith SW, Bertolone DT, Leone A, Bermpeis K, et al. International evaluation of an artificial intelligence-powered electrocardiogram model detecting acute coronary occlusion myocardial infarction. Eur Heart J Digit Health. 2023;5(2):123-33. doi:10.1093/ehjdh/ztad074.
  23. Antzelevitch C, Brugada P, Brugada J, Brugada R. Brugada syndrome: From cell to bedside. Heart Rhythm. 2005;2(4):356-60.
  24. Campuzano O, Sarquella-Brugada G, Arbelo E, Brugada J, Brugada R. Genetic basis of Brugada syndrome. Eur Heart J. 2019;40(16):1417-25
  25. Brugada J, Brugada R, Antzelevitch C, Towbin JA, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation. 2002;105(1):73-8.
  26. Mizusawa Y, Wilde AA. Brugada syndrome. Circ Arrhythm Electrophysiol. 2012;5(3):606-16.
  27. Keller DI, Rougier JS, Kucera JP, Benammar N, Fressart V, Guicheney P, et al. Brugada syndrome and fever: genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovasc Res. 2005;67(3):510-9.
  28. Mattu A, Brady WJ, Robinson DA. Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med. 2000;18(6):721-9.
  29. Wrenn KD, Slovis CM. The electrocardiographic manifestations of severe hyperkalemia. Am J Emerg Med. 1991;9(5):447-9.
  30. Szerlip HM, Weiss J, Singer I. Hyperkalemia in the emergency department. J Crit Care. 1991;6(3):225-32.
  31. Littmann L, Monroe MH. Electrocardiographic manifestations of severe hyperkalemia. J Electrocardiol. 2015;48(6):962-7.
  32. Powerful Medical. Clinical validations: PMcardio AI-powered ECG interpretation. Powerful Medical [Internet]. 2023 [cited 2024 Sep 24]. Available from: https://www.powerfulmedical.com/blog/clinical-validations/
  33. Powerful Medical. PMcardio for organizations: AI-powered ECG interpretation. Powerful Medical [Internet]. 2023 [cited 2024 Sep 24]. Available from: https://www.powerfulmedical.com/pmcardio-organizations/

Dr. Hana Hybasek Dzurikova, MRCVS, PGCert MEd

Dr. Hana Hybasek Dzurikova, MRCVS, PGCert MEd is a medical educator driving innovation and change in health professions education through technology-enhanced learning.
Dr. Hana Hybasek Dzurikova, MRCVS, PGCert MEd is a medical educator driving innovation and change in health professions education through technology-enhanced learning.
About PMcardio:

PMcardio is the market leader in AI-powered diagnostics, addressing the world’s leading cause of death – cardiovascular diseases. The innovative clinical assistant empowers healthcare professionals to detect up to 40 cardiovascular diseases. In the form of a smartphone application, the certified Class IIb medical device interprets any 12-lead ECG image in under 5 seconds to provide accurate diagnoses and individualized treatment recommendations tailored to each patient.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Powerful Medical’s Global Presence: A Month of Innovation and Collaboration

September has been an exhilarating month for the Powerful Medical team as we connected with global thought leaders, innovators, and clinicians at key international events. Our mission to push the boundaries of modern medicine with AI-driven solutions was at the forefront of these engagements.

Launch of the Post-ROSC ECG Analysis using AI (PEACE AI) Validation Study

We are excited to announce the latest multi-center validation study of our AI platform, PMcardio. This study evaluates the effectiveness of our AI model (Queen of Hearts) in detecting Occlusive Myocardial Infarction (OMI) using 12-lead ECGs recorded in patients who have been resuscitated after an out-of-hospital cardiac arrest (OHCA).

Join 25,000 healthcare professionals who are already taking advantage of AI